Ana Reis-Melo1,2, Maria do Céu Espinheira1, Isabel Pinto-Pais1, Artur Bonito Vitor3, Jacinta Bustamante4, Eunice Trindade1. 1. Pediatric Gastroenterology Unit, Centro Hospitalar Universitário do São João, Porto, Portugal. 2. Biomedicine Department, Faculdade de Medicina, Universidade do Porto, Porto, Portugal. 3. Pediatric Primary Immunodeficiencies Unit, Centro Hospitalar Universitário do São João, Porto, Portugal. 4. Centre d'Etudes des Déficits Immunitaires, Hôpital Necker Enfants-Malades, Paris, France.
Abstract
BACKGROUND: Chronic granulomatous disease (CGD) is a primary immunodeficiency due to a malfunction of NADPH oxidase. It is characterized by recurrent and severe infections caused by catalase-positive microorganisms and autoinflammatory manifestations. Recently, there has been described an NCF4 gene variant that causes a deficiency of p40<sup>phox</sup>, a subunit of NADPH oxidase. Patients with this deficiency appear to have a less severe clinical form as compared to classic CGD. CASE: A 15-year-old girl with vulvar lichen planus since she was 2 years old and suspected Crohn's disease (CD) was first seen at our hospital. At the age of 12 years, she had been submitted to sacrococcygeal cyst exeresis, without cicatrization of the surgical wound and extension of the lesion to the perianal area. The diagnosis of CD was questioned, and the patient underwent an endoscopic and radiologic assessment, which was normal. A skin biopsy from the perianal area revealed a granuloma; thus, CD with isolated perianal disease was assumed. After several different treatments including antibiotics, infliximab, and adalimumab, the perianal lesion persisted, with no associated gastrointestinal symptoms. Therefore, the hypothesis of an immunodeficiency was considered. An immunologic and genetic study revealed reduced oxidative burst in the phorbol myristate acetate test, with diminished reactive oxygen species production and a homozygous mutation in the NCF4 gene. The adolescent started prophylactic trimethoprim-sulfamethoxazole and became asymptomatic. CONCLUSIONS: The present case highlights that alternative diagnoses to CD must be considered in the presence of isolated perianal disease with granulomatous inflammation, especially when the disease is refractory to conventional CD therapy.
BACKGROUND: Chronic granulomatous disease (CGD) is a primary immunodeficiency due to a malfunction of NADPH oxidase. It is characterized by recurrent and severe infections caused by catalase-positive microorganisms and autoinflammatory manifestations. Recently, there has been described an NCF4 gene variant that causes a deficiency of p40<sup>phox</sup>, a subunit of NADPH oxidase. Patients with this deficiency appear to have a less severe clinical form as compared to classic CGD. CASE: A 15-year-old girl with vulvar lichen planus since she was 2 years old and suspected Crohn's disease (CD) was first seen at our hospital. At the age of 12 years, she had been submitted to sacrococcygeal cyst exeresis, without cicatrization of the surgical wound and extension of the lesion to the perianal area. The diagnosis of CD was questioned, and the patient underwent an endoscopic and radiologic assessment, which was normal. A skin biopsy from the perianal area revealed a granuloma; thus, CD with isolated perianal disease was assumed. After several different treatments including antibiotics, infliximab, and adalimumab, the perianal lesion persisted, with no associated gastrointestinal symptoms. Therefore, the hypothesis of an immunodeficiency was considered. An immunologic and genetic study revealed reduced oxidative burst in the phorbol myristate acetate test, with diminished reactive oxygen species production and a homozygous mutation in the NCF4 gene. The adolescent started prophylactic trimethoprim-sulfamethoxazole and became asymptomatic. CONCLUSIONS: The present case highlights that alternative diagnoses to CD must be considered in the presence of isolated perianal disease with granulomatous inflammation, especially when the disease is refractory to conventional CD therapy.
Authors: Juan D Matute; Andres A Arias; Nicola A M Wright; Iwona Wrobel; Christopher C M Waterhouse; Xing Jun Li; Christophe C Marchal; Natalie D Stull; David B Lewis; MacGregor Steele; James D Kellner; Weiming Yu; Samy O Meroueh; William M Nauseef; Mary C Dinauer Journal: Blood Date: 2009-08-19 Impact factor: 22.113
Authors: David J Keljo; James Markowitz; Christine Langton; Trudy Lerer; Athos Bousvaros; Ryan Carvalho; Wallace Crandall; Jonathan Evans; Anne Griffiths; Marsha Kay; Subra Kugathasan; Neal LeLeiko; David Mack; Petar Mamula; M Susan Moyer; Maria Oliva-Hemker; Anthony Otley; Marian Pfefferkorn; Joel Rosh; Jeffrey S Hyams Journal: Inflamm Bowel Dis Date: 2009-03 Impact factor: 5.325